Skip to main content

Published

Lessons from the PROTECT-CH COVID-19 platform trial in care homes.
Bath PM. Health Technology Assessment 2026;30(62):303-328.
[Coronavirus disease-2019 was associated with significant mortality and morbidity in care homes in 2020–1. Repurposed antiviral drugs might reduce morbidity and mortality through reducing viral transmission, infection, replication and inflammation. The authors aimed to compare the safety and efficacy of potential antiviral drugs in care home residents.]
Freely available online

More details
Age Groups
Older People
Conditions and Lifestyle Factors
Coronavirus Infections
Settings
Residential and Nursing Homes
Staff Groups
Manager
Medic
Non-Clinical Professional
Nurse Specialist
Public Health Doctor
Public Health Specialist